Literature DB >> 20504879

p53 is balancing development, differentiation and de-differentiation to assure cancer prevention.

Alina Molchadsky1, Noa Rivlin, Ran Brosh, Varda Rotter, Rachel Sarig.   

Abstract

Many of the roles played by the tumor suppressor p53 in restraining cancer initiation and progression are well established. These include the ability of p53 to induce cell-cycle arrest, DNA repair, senescence and apoptosis. In addition, during the 30 years of p53 research, numerous studies have implicated p53 in the regulation of differentiation and developmental pathways. Here, we summarize the data on these relatively less-characterized functions of p53, including its involvement in embryogenesis and various differentiation programs, as well as its function in restraining de-differentiation of mature somatic cells. Besides the well-known functions of p53 as a cell-cycle regulator and a mediator of apoptosis, both coincide with differentiation processes, p53 was shown to exert its effects on various differentiation programs via direct regulation of specific key factors controlling these programs. The complex regulation by p53, which acts to suppress or to induce differentiation, is mainly the result of the specific cell type and fate. We argue that regulation of differentiation is pivotal for the tumor-suppressive activity of p53, which act to maintain the proper cellular state, preventing improper maturation or reprogramming. This conclusion is further supporting the notion that aberrant differentiation is associated with malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504879     DOI: 10.1093/carcin/bgq101

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  78 in total

1.  VEGF is essential for the growth and migration of human hepatocellular carcinoma cells.

Authors:  Lei Zhang; Jia-Ning Wang; Jun-Ming Tang; Xia Kong; Jian-Ye Yang; Fei Zheng; Ling-Yun Guo; Yong-Zhang Huang; Li Zhang; Lin Tian; Shu-Fen Cao; Chang-Hai Tuo; Hong-Li Guo; Shi-You Chen
Journal:  Mol Biol Rep       Date:  2011-12-10       Impact factor: 2.316

2.  Measuring cell cycle progression kinetics with metabolic labeling and flow cytometry.

Authors:  Helen Fleisig; Judy Wong
Journal:  J Vis Exp       Date:  2012-05-22       Impact factor: 1.355

3.  Regulation of miR-34 Family in Neuronal Development.

Authors:  Abhishek Jauhari; Tanisha Singh; Parul Singh; Devendra Parmar; Sanjay Yadav
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

4.  Platelet-activating factor induces proliferation in differentiated keratinocytes.

Authors:  Astrid J Feuerherm; Katarina M Jørgensen; Randi M Sommerfelt; Live E Eidem; Astrid Lægreid; Berit Johansen
Journal:  Mol Cell Biochem       Date:  2013-08-24       Impact factor: 3.396

5.  SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63.

Authors:  Chamutal Bornstein; Ran Brosh; Alina Molchadsky; Shalom Madar; Ira Kogan-Sakin; Ido Goldstein; Deepavali Chakravarti; Elsa R Flores; Naomi Goldfinger; Rachel Sarig; Varda Rotter
Journal:  Mol Cell Biol       Date:  2011-02-07       Impact factor: 4.272

Review 6.  Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.

Authors:  Yu-Hsuan Lin; Brittany E Jewell; Julian Gingold; Linchao Lu; Ruiying Zhao; Lisa L Wang; Dung-Fang Lee
Journal:  Trends Mol Med       Date:  2017-07-20       Impact factor: 11.951

7.  Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.

Authors:  Izumi Horikawa; Kye-Yoon Park; Kazunobu Isogaya; Yukiharu Hiyoshi; Han Li; Katsuhiro Anami; Ana I Robles; Abdul M Mondal; Kaori Fujita; Manuel Serrano; Curtis C Harris
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

8.  p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition.

Authors:  R Brosh; Y Assia-Alroy; A Molchadsky; C Bornstein; E Dekel; S Madar; Y Shetzer; N Rivlin; N Goldfinger; R Sarig; V Rotter
Journal:  Cell Death Differ       Date:  2012-09-21       Impact factor: 15.828

Review 9.  The A to Z of modulated cell patterning by mammalian thioredoxin reductases.

Authors:  Markus Dagnell; Edward E Schmidt; Elias S J Arnér
Journal:  Free Radic Biol Med       Date:  2017-12-24       Impact factor: 7.376

10.  Interleukin Enhancer Binding Factor 2 Regulates Cell Viability and Apoptosis of Human Brain Vascular Smooth Muscle Cells.

Authors:  Liang Wei; Cheng Yang; Guangxue Wang; Keqin Li; Yanfei Zhang; Hongxin Guan; Zhiyang Sun; Chunlong Zhong
Journal:  J Mol Neurosci       Date:  2020-08-04       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.